Support Alert

Company led medicines recall: Mawdsley-Brooks & Company Limited, Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection

Mawdsley-Brooks & Company Limited is recalling specific batches of Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for injection as a precautionary measure, due to validation tests demonstrating the leaching of filter additives that are above the acceptable limit.

Further information, advice and details of the affected batches can be found on the MHRA website.

Loading...
Stageofcareerqualify

Are you ready for 2023?

Renew your RPS membership for 2023, so you're ready for whatever the year brings!

Renew today AND find out how to save money on your membership in 2023.

SAVE MONEY ON YOUR MEMBERSHIP